Metabolic reprogramming and drug resistance in hepatocellular carcinoma: The emerging role of SREBP2-driven cholesterol metabolism

Biochimica et Biophysica Acta: Biomembranes · Elsevier

Аннотация

Publication date: September 2026 Source: Drug Discovery Today, Volume 31, Issue 5 Author(s): Veerababu Nagati, Swathi Tenugu, Miguel Salazar, Manish K. Tripathi

Читать у издателя →

Похожие статьи